|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
230,290,000 |
Market
Cap: |
138.17(K) |
Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,994 |
52
Week Range: |
$0.0001 - $0.055 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Loverro Frank J |
10% Owner |
|
2005-10-20 |
4 |
OE |
$2.42 |
$56,968 |
I/I |
20,961 |
18,473,845 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-10-20 |
4 |
OE |
$2.42 |
$68,130 |
D/D |
25,068 |
22,093,979 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-10-19 |
4 |
OE |
$2.42 |
$208,777 |
I/I |
79,682 |
17,059,368 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-10-19 |
4 |
OE |
$2.42 |
$226,345 |
I/I |
86,387 |
18,494,805 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-10-19 |
4 |
OE |
$2.42 |
$270,696 |
D/D |
103,314 |
22,119,047 |
|
- |
|
Kelso Partners V L P |
10% Owner |
|
2005-10-19 |
4 |
OE |
$2.42 |
$208,777 |
I/I |
79,682 |
17,059,368 |
|
- |
|
Kelso Equity Partners V L P |
10% Owner |
|
2005-10-19 |
4 |
OE |
$2.42 |
$226,345 |
I/I |
86,387 |
18,494,805 |
|
- |
|
Kelso Investment Assoc V L P |
10% Owner |
|
2005-10-19 |
4 |
OE |
$2.42 |
$226,345 |
I/I |
86,387 |
18,494,805 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-10-18 |
4 |
OE |
$2.42 |
$53,262 |
I/I |
20,256 |
17,139,050 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-10-18 |
4 |
OE |
$2.42 |
$57,740 |
I/I |
21,959 |
18,581,191 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-10-18 |
4 |
OE |
$2.42 |
$69,054 |
D/D |
26,262 |
22,222,361 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-10-17 |
4 |
OE |
$2.42 |
$73,823 |
I/I |
29,282 |
17,159,304 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-10-17 |
4 |
OE |
$2.42 |
$80,034 |
I/I |
31,746 |
18,603,150 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-10-17 |
4 |
OE |
$2.42 |
$95,718 |
D/D |
37,967 |
22,248,623 |
|
- |
|
Kelso Partners V L P |
10% Owner |
|
2005-10-17 |
4 |
OE |
$2.42 |
$73,823 |
I/I |
29,282 |
17,159,304 |
|
- |
|
Kelso Equity Partners V L P |
10% Owner |
|
2005-10-17 |
4 |
OE |
$2.42 |
$80,034 |
I/I |
31,746 |
18,603,150 |
|
- |
|
Kelso Investment Assoc V L P |
10% Owner |
|
2005-10-17 |
4 |
OE |
$2.42 |
$80,034 |
I/I |
31,746 |
18,603,150 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-10-14 |
4 |
OE |
$2.42 |
$163,651 |
I/I |
57,427 |
17,188,586 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-10-14 |
4 |
OE |
$2.42 |
$177,424 |
I/I |
62,260 |
18,634,896 |
|
- |
|
Kelso Partners V L P |
10% Owner |
|
2005-10-14 |
4 |
OE |
$2.42 |
$163,651 |
I/I |
57,427 |
17,188,586 |
|
- |
|
Kelso Equity Partners V L P |
10% Owner |
|
2005-10-14 |
4 |
OE |
$2.42 |
$177,424 |
I/I |
62,260 |
18,634,896 |
|
- |
|
Kelso Investment Assoc V L P |
10% Owner |
|
2005-10-14 |
4 |
OE |
$2.42 |
$177,424 |
I/I |
62,260 |
18,634,896 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-10-14 |
4 |
OE |
$2.42 |
$212,193 |
D/D |
74,461 |
22,286,590 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-10-13 |
4 |
OE |
$2.42 |
$130,746 |
I/I |
49,931 |
17,246,015 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-10-13 |
4 |
OE |
$2.42 |
$141,749 |
I/I |
54,133 |
18,697,157 |
|
- |
|
825 Records found
|
|
Page 26 of 33 |
|
|